At the same time, the IFN-enriched microenvironment generated by tumor cell RIG-I signaling increases expression of major histocompatibility complex (MHC)-II antigen presentation molecules in macrophages and DCs, which may further increase tumor antigen cross-presentation. This evidence concerns the gene RIGI and neoplasm.